70 related articles for article (PubMed ID: 32469065)
21. Miliary Tuberculosis during R-MPV Therapy in an Elderly Patient with Primary Central Nerve System Lymphoma: A Case Report.
Take Y; Shirahata M; Sakai J; Kubota Y; Suzuki T; Adachi JI; Maesaki S; Mishima K; Nishikawa R
Case Rep Oncol; 2023; 16(1):1054-1059. PubMed ID: 37900802
[TBL] [Abstract][Full Text] [Related]
22. HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series.
Seidel S; Kowalski T; Margold M; Baraniskin A; Schroers R; Martus P; Schlegel U
Ther Adv Neurol Disord; 2020; 13():1756286420951087. PubMed ID: 33101460
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study.
Herzi D; Le Garff-Tavernier M; Sourdeau E; Choquet S; Soussain C; Nichelli L; Mathon B; Mokhtari K; Laurenge A; Alentorn A; Boussen I; Alcantara M; Hoang-Xuan K; Houillier C
Neurology; 2024 Jun; 102(12):e209527. PubMed ID: 38830184
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of high-dose methotrexate completion for primary central nervous system lymphoma using modified Geriatric 8 for functional assessment: A retrospective descriptive study.
Matsunuma S; Koshiishi T; Sunaga S; Otsuka K; Okumura E; Yoshimoto K; Jimbo H
J Geriatr Oncol; 2024 Apr; 15(3):101704. PubMed ID: 38245426
[No Abstract] [Full Text] [Related]
25. Primary histiocytic sarcoma of the central nervous system.
So H; Kim SA; Yoon DH; Khang SK; Hwang J; Suh CH; Suh C
Cancer Res Treat; 2015 Apr; 47(2):322-8. PubMed ID: 25345462
[TBL] [Abstract][Full Text] [Related]
26. Venetoclax with high-dose methotrexate and rituximab seem effective and well-tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report.
Beziat G; Gauthier M; Protin C; Oberic L; Lerebours F; Carlier J; Ysebaert L
Clin Case Rep; 2020 Feb; 8(2):269-273. PubMed ID: 32128171
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate induced lung injury in a patient with primary CNS lymphoma: a case report.
Chhabra P; Law AD; Suri V; Malhotra P; Varma S
Mediterr J Hematol Infect Dis; 2012; 4(1):e2012020. PubMed ID: 22550565
[TBL] [Abstract][Full Text] [Related]
28. Have we reached the end of the road for radiation therapy in primary central nervous system lymphoma?
Kaliyath SB; Sharma DN
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S1018-S1019. PubMed ID: 38261455
[No Abstract] [Full Text] [Related]
29. A case of primary central-nervous system lymphoma with no obvious effect of hormone therapy.
Liu Y; Cai L; Zhou Y
Asian J Surg; 2024 Apr; 47(4):2008-2009. PubMed ID: 38212218
[No Abstract] [Full Text] [Related]
30. Association Between Pesticide Use and Incidence of Diffuse Large B-Cell Lymphoma.
Altahan A; Harris LJ; Porta J; Jain AL; Martin MG
Anticancer Res; 2020 Oct; 40(10):5423-5426. PubMed ID: 32988863
[TBL] [Abstract][Full Text] [Related]
31. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X
J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699
[TBL] [Abstract][Full Text] [Related]
32. Consolidation Therapy in Primary Central Nervous System Lymphoma.
Kim P; Omuro A
Curr Treat Options Oncol; 2020 Jul; 21(9):74. PubMed ID: 32725379
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the outcomes of patients with primary central nervous system lymphoma between the neurosurgery and hematology/oncology departments based on the relative dose intensity of methotrexate.
Hosoi H; Okamura T; Fukai J; Hori Y; Murata S; Mushino T; Nakao N; Sonoki T
Oncol Lett; 2023 Nov; 26(5):469. PubMed ID: 37809042
[TBL] [Abstract][Full Text] [Related]
34. A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma.
Suzuki Y; Imoto N; Ishihara S; Fujiwara S; Ito R; Sakai T; Yamamoto S; Sugiura I; Kurahashi S
Intern Med; 2022 May; 61(9):1345-1352. PubMed ID: 34670884
[TBL] [Abstract][Full Text] [Related]
35. Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy.
Sasaki N; Kobayashi K; Saito K; Shimizu S; Suzuki K; Lee J; Yamagishi Y; Shibahara J; Takayama N; Shiokawa Y; Nagane M
Jpn J Clin Oncol; 2020 Sep; 50(9):999-1008. PubMed ID: 32469065
[TBL] [Abstract][Full Text] [Related]
36. Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.
Houillier C; Ghesquières H; Chabrot C; Soussain C; Ahle G; Choquet S; Nicolas-Virelizier E; Bay JO; Vargaftig J; Gaultier C; Touitou V; Martin-Duverneuil N; Cassoux N; Le Garff-Tavernier M; Costopoulos M; Faurie P; Hoang-Xuan K
J Neurooncol; 2017 Jun; 133(2):315-320. PubMed ID: 28432587
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
Omuro A; Chinot O; Taillandier L; Ghesquieres H; Soussain C; Delwail V; Lamy T; Gressin R; Choquet S; Soubeyran P; Huchet A; Benouaich-Amiel A; Lebouvier-Sadot S; Gyan E; Touitou V; Barrié M; del Rio MS; Gonzalez-Aguilar A; Houillier C; Delgadillo D; Lacomblez L; Tanguy ML; Hoang-Xuan K
Lancet Haematol; 2015 Jun; 2(6):e251-9. PubMed ID: 26688235
[TBL] [Abstract][Full Text] [Related]
38. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Morris PG; Correa DD; Yahalom J; Raizer JJ; Schiff D; Grant B; Grimm S; Lai RK; Reiner AS; Panageas K; Karimi S; Curry R; Shah G; Abrey LE; DeAngelis LM; Omuro A
J Clin Oncol; 2013 Nov; 31(31):3971-9. PubMed ID: 24101038
[TBL] [Abstract][Full Text] [Related]
39. High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials.
Yu J; Du H; Ye X; Zhang L; Xiao H
Sci Rep; 2021 Jan; 11(1):2125. PubMed ID: 33483528
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
